Real‐world experience of direct oral anticoagulant use in a single pediatric center
GG Valenti, C Sabo, M Hyde… - Pediatric Blood & …, 2024 - Wiley Online Library
Background Pediatric venous thromboembolism has increased by 130%–200%, specifically
in hospitalized children, and direct oral anticoagulants (DOACs) offer several therapeutic …
in hospitalized children, and direct oral anticoagulants (DOACs) offer several therapeutic …
Enoxaparin treatment dosing for venous thromboembolism in pediatric patients with obesity
J Yim, A Jahan, N Braykov… - Pediatric Blood & …, 2024 - Wiley Online Library
Background The optimal enoxaparin dosing for treatment of venous thromboembolism (VTE)
in pediatric patients with obesity remains uncertain. We described the mean enoxaparin …
in pediatric patients with obesity remains uncertain. We described the mean enoxaparin …
Procedural outcomes in children with mild type 1 von Willebrand disease
S Heery, K Zimowski, SF Mason, MH White… - Research and Practice …, 2024 - Elsevier
Background In patients with mild type 1 von Willebrand disease (VWD), treatment guidelines
suggest individualization of surgical management. However, these conditional …
suggest individualization of surgical management. However, these conditional …
[HTML][HTML] Improving Anticoagulation Care for Pediatric Oncology Patients: A Quality Improvement Initiative
V Rodriguez, BS Mitchell, J Stanek… - Pediatric Quality & …, 2024 - journals.lww.com
Background: Cancer is associated with increased venous thromboembolism in children.
Risk factors for venous thromboembolism in this cohort include using central venous …
Risk factors for venous thromboembolism in this cohort include using central venous …